<DOC>
	<DOCNO>NCT00048932</DOCNO>
	<brief_summary>The purpose clinical research study learn abatacept safe co-administered approve rheumatoid arthritis medication .</brief_summary>
	<brief_title>A Phase III Study BMS-188667 Subjects With Active Rheumatoid Arthritis</brief_title>
	<detailed_description>This multinational , multicenter , randomize , double-blind , 2-arm , parallel-dosing design study . The treatment period 12 month . Eligible participant randomize 1 2 treatment group : abatacept fix dose approximate 10 mg/kg ( base participant 's body weight ; 500 mg participant weigh &lt; 60kg ; 750 mg participant weigh 60 100 kg ; 1 gram participant weigh &gt; 100 kg , monthly ) placebo intravenous ( IV ) infusion . All participant continue background therapy ( y ) rheumatoid arthritis ( RA ) ( non-biologic biologic disease-modifying drug [ DMARDs ] , combination ) throughout double-blind treatment period . Double-blind study medication ( abatacept placebo ) administer Days 1 , 15 , 29 , every 28 day thereafter , total 14 dos . All participant complete 12-month double-blind study period ( Day 1 Day 365 ) , eligible continue open-label period . All eligible participant ( active placebo ) re-allocated receive abatacept weight-tiered dose approximate 10 mg/kg , base Day 365 body weight . Participants continue receive infusion every 28 day .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Meet criterion American Rheumatism Association diagnosis rheumatoid arthritis American College Rheumatology functional class I , II III IV Participants must take 1 DMARDs and/or biologic approve rheumatoid arthritis ( RA ) least 3 month stable dose 28 day prior Day 1 . Exclusion : Other autoimmune disease main diagnosis ( e.g . Systemic Lupus Erythematosus [ SLE ] , Scleroderma ) Active tuberculosis ( TB ) require treatment within last 3 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>